Actuate Therapeutics, Inc. (ACTU) Ownership
ACTU ownership summary
as of October 18, 2026- Institutions
- 56.3% of shares outstanding
- Insiders
- 15.41% of shares outstanding
- Shares outstanding
- 24.0M
- Float
- 8.6M shares available to trade
- Short interest
- 12.59% 1.3M shares short
- Days to cover
- 4.60 short interest up 21.2% vs prior month
- Institutions 56.27%
- Insiders 15.41%
- Other investors 28.32%
ACTU top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BIOS CAPITAL MANAGEMENT, LP | 41.85% | 10.0M | $6.1M | — | June 30, 2026 |
| 2 | Voss Capital LLC | 7.18% | 1.7M | $1.0M | — | June 30, 2026 |
| 3 | Vanguard Capital Management, LLC | 1.64% | 393K | $238,027 | −7,096 (−1.8%) | June 30, 2026 |
| 4 | Palogic Value Management LP | 0.83% | 200K | $121,000 | +100,000 (+100.0%) | June 30, 2026 |
| 5 | AQR Capital Management LLC | 0.53% | 127K | $77,133 | +100,384 (+370.3%) | June 30, 2026 |
| 6 | Geode Capital Management, LLC | 0.47% | 113K | $68,095 | −115,777 (−50.7%) | June 30, 2026 |
| 7 | Texas Capital Bank Wealth Management Services Inc | 0.43% | 103K | $62,080 | +8,020 (+8.5%) | June 30, 2026 |
| 8 | Millennium Management LLC | 0.40% | 97K | $58,494 | +96,684 (0.0%) | June 30, 2026 |
| 9 | BlackRock Inc | 0.37% | 90K | $54,471 | −337,118 (−78.9%) | June 30, 2026 |
| 10 | ABS Investment Management LLC | 0.30% | 73K | $44,278 | +73,186 (0.0%) | June 30, 2026 |
| 11 | ABS Direct Equity Fund LLC | 0.30% | 73K | $44,278 | +23,186 (+46.4%) | June 30, 2026 |
| 12 | Vanguard Fiduciary Trust Co | 0.23% | 54K | $32,971 | −8,095 (−12.9%) | June 30, 2026 |
| 13 | Rock Creek Group, LP | 0.16% | 39K | $23,754 | — | June 30, 2026 |
| 14 | Jane Street Group LLC | 0.16% | 39K | $23,675 | +39,132 (0.0%) | June 30, 2026 |
| 15 | HighTower Advisors, LLC | 0.15% | 36K | $22,059 | +36,461 (0.0%) | June 30, 2026 |
| 16 | The Goldman Sachs Group Inc | 0.15% | 35K | $21,476 | +23,090 (+186.1%) | June 30, 2026 |
| 17 | Sfmg LLC | 0.14% | 33K | $19,965 | — | June 30, 2026 |
| 18 | Susquehanna International Group, LLP | 0.12% | 28K | $17,050 | +28,182 (0.0%) | June 30, 2026 |
| 19 | Bridgeway Capital Management, LLC | 0.10% | 23K | $14,207 | −7,500 (−24.2%) | June 30, 2026 |
| 20 | State Street Corp | 0.09% | 22K | $13,219 | −44,180 (−66.9%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 10 holders added 528K shares and 6 cut 520K.
ACTU top mutual fund and ETF holders
10 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 1.20% | 287K | $173,868 | — | August 31, 2026 |
| 2 | Fidelity Extended Market Index | 0.27% | 64K | $38,546 | +15,859 (+33.1%) | August 31, 2026 |
| 3 | iShares Micro-Cap ETF | 0.15% | 36K | $22,063 | −251 (−0.7%) | September 30, 2026 |
| 4 | EA Bridgeway Ultra-Small Company Mkt ETF | 0.10% | 23K | $14,012 | — | September 30, 2026 |
| 5 | Fidelity Total Market Index | 0.06% | 14K | $8,223 | — | August 31, 2026 |
| 6 | Fidelity Series Total Market Index | 0.05% | 12K | $7,412 | — | August 31, 2026 |
| 7 | Vanguard U.S. Eq Idx £ Acc | 0.02% | 5,102 | $3,087 | — | August 31, 2026 |
| 8 | Fidelity Nasdaq Composite Index | 0.01% | 3,492 | $2,113 | −16,818 (−82.8%) | August 31, 2026 |
| 9 | 1290 VT Micro Cap K | 0.01% | 1,700 | $1,028 | — | August 31, 2026 |
| 10 | BlackRock Small Cap Index V.I. I | <0.01% | 91 | $55 | −1,328 (−93.6%) | June 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
ACTU insider transactions
latest 4| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-05 | Todd S Thomson | Sell | $5.80 | 280,000 | $1.6M |
| 2025-06-27 | Aaron G.L. Fletcher | Buy | $7.00 | 71,428 | $499,996 |
| 2025-06-27 | Equity Cof Lp Bios | Buy | $7.00 | 71,428 | $499,996 |
| 2025-06-27 | Leslie W Kreis | Buy | $7.00 | 71,428 | $499,996 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
ACTU shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns ACTU
Institutional investors own 56.3% of Actuate Therapeutics's shares and insiders 15.41%. The largest holder is BIOS CAPITAL MANAGEMENT, LP with 41.85% of the shares (10.0M), as of June 30, 2026. Among the top 20 institutions, 10 added shares and 6 reduced their stake in the latest filings. Short interest is 12.59% of the float, or 4.60 days of average trading volume. The share count rose 52.3% since 2023.
Related: ACTU analyst forecast, ACTU key metrics. See the ACTU stock overview for the latest quote and news.
ACTU ownership FAQ
Who owns the most Actuate Therapeutics stock?
The largest shareholders of Actuate Therapeutics are BIOS CAPITAL MANAGEMENT, LP (41.85%), Voss Capital LLC (7.18%), Vanguard Capital Management, LLC (1.64%), Palogic Value Management LP (0.83%), AQR Capital Management LLC (0.53%).
What percentage of Actuate Therapeutics is owned by institutions?
Institutions hold 56.3% of Actuate Therapeutics's shares outstanding; insiders hold 15.41%.
Which funds own Actuate Therapeutics?
The largest fund holders of Actuate Therapeutics are Vanguard MStar Total Stk Mkt Idx Invest (1.20%), Fidelity Extended Market Index (0.27%), iShares Micro-Cap ETF (0.15%), EA Bridgeway Ultra-Small Company Mkt ETF (0.10%), Fidelity Total Market Index (0.06%).
What is Actuate Therapeutics's short interest?
1.3M shares of Actuate Therapeutics were sold short, 12.59% of the float; at the average daily volume it would take 4.60 days to cover.
Are insiders buying or selling Actuate Therapeutics?
Of the latest 4 reported insider transactions in Actuate Therapeutics (since June 27, 2025), 3 were purchases and 1 were sales.
How many shares of Actuate Therapeutics are outstanding?
Actuate Therapeutics has 24.0M shares outstanding, of which 8.6M are in the public float.